STAAR SURGICAL CO

STAA · Nasdaq · SIC 3851: Ophthalmic Goods
316
SEC Filings

Business Summary

, for a discussion of: Operations Principal Products Distribution and Customers Competition Regulatory Matters Research and Development Strategic Imperatives for 2026 We believe we have a significant opportunity to fundamentally transform how myopia and other refractive conditions are treated. We want to be the first choice for doctors and for patients seeking visual freedom from wearing eyeglasses or contact lenses. The Company is navigating market headwinds, geopolitical factors and a dynamic ...

Next Earnings

Q2 FY2026 — expected 2026-09-11

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionSTAAdiscussed_in_filing Cybersecurity
topic_mentionSTAAdiscussed_in_filing Cybersecurity
topic_mentionSTAAdiscussed_in_filing Regulation
topic_mentionSTAAdiscussed_in_filing Regulation

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-032026-01-020000718937-26-000004EDGAR70K words
2025-02-212024-12-270000950170-25-024813EDGAR—
2024-02-272023-12-290000950170-24-020572EDGAR—
2023-02-232022-12-300001564590-23-002249EDGAR—
2022-02-232021-12-310001564590-22-006264EDGAR—
2021-02-242021-01-010001564590-21-008098EDGAR—
2020-02-262020-01-030001564590-20-006791EDGAR—
2019-02-212018-12-280001564590-19-003674EDGAR—
2018-02-282017-12-290001144204-18-011838EDGAR—
2017-03-022016-12-300001144204-17-012557EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-052025-09-260001193125-25-266879EDGAR25K words
2025-08-062025-06-270000950170-25-103982EDGAR—
2025-05-072025-03-280000950170-25-065665EDGAR—
2024-10-302024-09-270000950170-24-118973EDGAR—
2024-08-072024-06-280000950170-24-092753EDGAR—
2024-05-072024-03-290000950170-24-054488EDGAR—
2023-11-062023-09-290000950170-23-058994EDGAR—
2023-08-022023-06-300000950170-23-037163EDGAR—
2023-05-032023-03-310000950170-23-017183EDGAR—
2022-11-022022-09-300001564590-22-036363EDGAR—
2022-08-102022-07-010001564590-22-028946EDGAR—
2022-05-042022-04-010001564590-22-017859EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-030000718937-26-000005EDGAR12K words
2026-02-050001193125-26-038534EDGAR—
2026-02-020001193125-26-032630EDGAR—
2026-01-160001193125-26-014681EDGAR—
2026-01-150001193125-26-013622EDGAR—
2026-01-060001193125-26-004699EDGAR—
2026-01-060001193125-26-003534EDGAR—
2025-12-090001193125-25-311982EDGAR—
2025-12-080001193125-25-310631EDGAR—
2025-11-070001193125-25-271708EDGAR—

316 total filings indexed. 284 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

BLCO — Bausch & Lomb Corp COO — COOPER COMPANIES, INC. LUCY — Innovative Eyewear Inc EYE — National Vision Holdings, Inc. RXST — RxSight, Inc. WRBY — Warby Parker Inc.

Company Identity

CIK0000718937
TickerSTAA
ExchangeNasdaq
SIC3851: Ophthalmic Goods
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 158695e892d97f6ad4167a5c2d0bbc431c2370a3127b0539df9dedc3e099d11e
parent: 25023cc9c8f769ebcf1ec5a8cbcd5e06f95471c1a1820abe9e990b3295178863
content hash: 03446653300f5382d61564dbbf7272bf52c04afe0779fb0bb0e3862cf9e40db1
signed: 2026-04-13T04:47:37.260Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf